US gives nod to Pfizer Covid vaccine for children aged 5-11
By MYBRANDBOOK
The United States has authorized the Pfizer Covid vaccine for children aged five-to-11, paving the way for 28 million young Americans to soon get immunized. The decision came after a high-level medical panel advising the government this week endorsed the shots, ruling that the known benefits outweighed the risks of side-effects.
"As a mother and a physician, I know that parents, caregivers, school staff, and children have been waiting for today's authorization," said acting Food and Drug Administration Chief Janet Woodcock in a statement.
The vaccine rollout should begin in earnest after the Centers for Disease Control and Prevention convenes a panel on Tuesday to further discuss clinical recommendations. Pfizer and its partner BioNTech announced this week.
The US government had bought 50 million more doses as it works to protect children, including eventually those under five. In a clinical trial involving more than 2,000 participants was found to be more than 90 percent effective at preventing symptomatic disease. The vaccine's safety was also studied in more than 3,000 children, and no serious side effects have been detected in the ongoing study. In this age group, the vaccine is given as two shots three weeks apart, dosed at 10 micrograms -- a third what is given to older age groups. Severe Covid is rarer in children than adults, but far from non-existent.
According to the CDC, there have been 8,300 Covid hospitalizations of children aged five-to-11 since the start of the pandemic, and 146 deaths. There have also been more than 5,000 pediatric cases of multisystem inflammatory syndrome in children (MIS-C), a rare but highly serious post-viral complication, including 46 deaths. Health authorities will continue to monitor for potentially highly rare side-effects, such as myocarditis and pericarditis (heart inflammation and inflammation around the heart). The clinical trials were too small to detect these, but the hypothesis is they will be exceedingly rare, because the effect is thought linked to testosterone levels.
Nazara and ONDC set to transform in-game monetization with ‘
Nazara Technologies has teamed up with the Open Network for Digital Comme...
Jio Platforms and NICSI to offer cloud services to government
In a collaborative initiative, the National Informatics Centre Services In...
BSNL awards ₹5,000 Cr Project to RVNL-Led Consortium
A syndicate led by Rail Vikas Nigam Limited (abbreviated as RVNL), along wi...
Pinterest tracks users without consent, alleges complaint
A recent complaint alleges that Pinterest, the popular image-sharing platf...
STERLITE TECHNOLOGIES LTD.
MICROTEK INTERNATIONAL PVT. LTD.
TALLY SOLUTIONS PVT. LTD.
EXIDE INDUSTRIES LTD.
Icons Of India : ALOK OHRIE
Alok Ohrie leads Dell Technologies’ India business, overseeing Sales...
ICONS OF INDIA : RISHAD PREMJI
Rishad Premji is Executive Chairman of Wipro Limited, a $11.3 billion ...
ICONS OF INDIA : RAJESH NAMBIAR
Rajesh leads the company’s India associates and enhances relationshi...
ITI - ITI Limited
ITI Limited is a leading provider of telecommunications equipment, sol...
BSE - Bombay Stock Exchange
The Bombay Stock Exchange (BSE) is one of India’s largest and oldest...
IFFCO - Indian Farmers Fertiliser Cooperative
IFFCO operates as a cooperative society owned and controlled by its fa...
Indian Tech Talent Excelling The Tech World - ARVIND KRISHNA, CEO – IBM
Arvind Krishna, an Indian-American business executive, serves as the C...
Indian Tech Talent Excelling The Tech World - REVATHI ADVAITHI, CEO- Flex
Revathi Advaithi, the CEO of Flex, is a dynamic leader driving growth ...
Indian Tech Talent Excelling The Tech World - Steve Sanghi, Executive Chair, Microchip
Steve Sanghi, the Executive Chair of Microchip Technology, has been a ...